Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Copanlisib on Metformin PK/PD in Healthy Volunteers
NCT03655301Phase 1Completed
- Sponsor
- Bayer
- Start
- Sep 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of copanlisib in follicular lymphoma (FL), sponsored by Bayer. Primary endpoints: Maximum Drug Concentration of Metformin in Plasma at Day 8, Area Under the Plasma Concentration Versus Time Curve From Zero to 24 Hours of Metformin and 1 more. Started Sep 2018; status: completed.
02
Drugs
copanlisib
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT03655301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03655301.